Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Betamethasone in Impacted Lower Third Molar Surgery
NCT07297264Phase 3Terminated
- Start
- Jan 2022
- Primary completion
- Feb 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of betamethasone. Started Jan 2022; status: terminated.
02
Drugs
betamethasone
Beyond the preview
Go deeper on NCT07297264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07297264.